Allogene Therapeutics Balance Sheet (2017-2026)

Reported Financials

Allogene Therapeutics Quarterly Balance Sheet

Periods 36 quarters

Latest Sep 2026

Allogene Therapeutics reported total assets of $511.32M and total liabilities of $118.77M for the quarter ended Sep 2026, up 16.3% year over year. This balance sheet covers 36 quarters of results from Dec 2017 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026	Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.	173.31M	84.51M	96.04M	74.36M	61.90M	109.93M	154.76M	69.25M	83.16M	51.04M	170.67M	51.24M	75.22M	42.46M	52.33M	37.82M	51.69M	30.31M	38.63M	29.27M
Short-term InvestmentsInvestments (Current)	283.99M	364.54M	394.45M	477.87M	455.42M	361.29M	337.20M	396.26M	365.54M	333.82M	273.96M	240.33M	217.26M	237.59M	220.79M	214.38M	198.52M	236.58M	293.98M	263.69M
Cash & Current Investments	457.30M	364.54M	394.45M	477.87M	517.32M	361.29M	337.20M	396.26M	448.70M	384.86M	444.63M	291.56M	292.48M	280.04M	273.12M	252.19M	250.21M	266.89M	332.60M	292.96M
Receivables - NetNet Receivables
Receivables - OtherOther Receivables	4.10M	9.40M	10.20M	4.30M	1.50M	1.20M
Receivables
Prepaid Assets	14.02M	20.69M	22.54M	16.83M	11.50M	10.24M	10.14M	7.95M	10.42M	10.50M	12.50M	12.85M	10.91M	11.53M	9.54M	8.53M	7.54M	6.41M	7.40M	6.87M
Current Assets	471.32M	469.74M	513.03M	569.06M	528.82M	481.47M	502.10M	473.45M	459.12M	395.36M	457.12M	304.42M	303.39M	291.58M	282.66M	260.72M	257.75M	273.29M	340.00M	299.83M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)	122.99M	120.20M	117.22M	114.44M	112.84M	109.85M	106.39M	102.83M	99.48M	95.93M	92.08M	88.99M	86.06M	82.99M	78.86M	75.90M	72.84M	70.02M	67.38M	64.82M
Long-Term Investments	352.18M	284.09M	195.64M	85.11M	59.15M	42.79M	52.59M	32.17M	3.65M	12.41M	1.13M	111.82M	80.67M	55.51M	29.51M	24.94M	8.04M		90.99M	95.92M
Intangibles
Goodwill & Intangibles
Other Non-Current Assets	16.11M	19.33M	19.23M	19.67M	19.86M	19.68M	19.67M	19.87M	16.90M	15.45M	16.73M	15.26M	12.62M	12.19M	14.12M	13.81M	13.91M	13.82M	13.98M	14.12M
Non-Current Assets	579.51M	508.35M	442.59M	325.42M	292.76M	268.66M	270.91M	239.96M	183.72M	190.99M	189.76M	284.71M	245.32M	216.41M	187.94M	179.05M	158.16M	122.67M	210.09M	211.49M
Assets	1,050.83M	978.09M	955.62M	894.48M	821.58M	750.13M	773.01M	713.41M	642.84M	586.35M	646.88M	589.12M	548.71M	507.98M	470.59M	439.77M	415.91M	395.96M	550.09M	511.32M
Liabilities
Current Liabilities
Accounts Payables	10.26M	8.71M	9.71M	11.05M	13.89M	14.69M	10.23M	6.21M	5.90M	5.78M	12.94M	5.51M	5.39M	5.06M	4.85M	3.70M	4.27M	4.93M	5.96M	8.78M
Notes Payables
Payables	10.26M	8.71M	9.71M	11.05M	13.89M	14.69M	10.23M	6.21M	5.90M	5.78M	12.94M	5.51M	5.39M	5.06M	4.85M	3.70M	4.27M	4.93M	5.96M	8.78M
Accumulated Expenses	37.50M	27.76M	34.36M	36.94M	39.74M	44.62M	44.26M	31.20M	31.18M	25.03M	24.37M	27.07M	30.13M	24.96M	26.82M	28.13M	28.24M	23.40M	25.76M	29.72M
Other Accumulated Expenses	1.75M	36.88M	44.91M	48.87M	2.12M	59.59M	54.72M	37.64M	1.81M				1.07M				2.40M
Current Deferred Revenue	0.16M	0.15M	0.10M	0.10M	0.10M	0.09M	0.09M	0.09M	0.09M	0.09M
Total Current Liabilities	47.91M	36.62M	44.18M	48.08M	53.73M	59.40M	54.58M	37.49M	37.08M	30.89M	37.31M	32.57M	35.52M	30.02M	31.68M	31.83M	32.51M	28.33M	31.73M	38.50M
Non-Current Liabilities
Preferred Stock Liabilities
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax						3.14M				3.08M	3.08M	3.08M		3.08M	3.08M	3.08M
Operating Leases	69.93M	69.04M	98.23M	96.71M	95.12M	93.51M	91.82M	90.10M	88.35M	88.92M	86.99M	85.14M	83.25M	81.29M	79.24M	77.13M	75.05M	72.63M	70.35M	68.04M
Other Non-Current Liabilities	7.79M	7.17M	6.73M	6.29M	5.85M	5.21M	5.20M	5.19M	5.18M	5.17M	7.55M	7.67M	7.76M	11.28M	15.12M	15.48M	15.80M	16.12M	11.84M	12.23M
Total Non-Current Liabilities	117.84M	105.65M	142.41M	144.79M	148.85M	152.91M	146.40M	127.59M	125.43M	119.81M	124.29M	117.71M	118.77M	111.31M	110.92M	108.97M	107.56M	100.96M	102.08M	106.54M
Total Liabilities	125.63M	112.82M	149.14M	151.08M	154.70M	158.12M	151.60M	132.78M	130.60M	124.98M	131.85M	125.37M	126.53M	122.59M	126.03M	124.44M	123.36M	117.08M	113.92M	118.77M
Shareholder's Equity
Total Debt
Common Equity	925.20M	865.27M	806.48M	743.40M	666.88M	592.01M	621.41M	580.64M	512.23M	461.37M	515.04M	463.75M	422.18M	385.39M	344.56M	315.33M	292.54M	278.88M	436.18M	392.55M
Liabilities and Shareholders Equity	1,050.83M	978.09M	955.62M	894.48M	821.58M	750.13M	773.01M	713.41M	642.84M	586.35M	646.88M	589.12M	548.71M	507.98M	470.59M	439.77M	415.91M	395.96M	550.09M	511.32M
Retained Earnings	-894.55M	-973.16M	-1,053.45M	-1,137.69M	-1,234.97M	-1,334.94M	-1,414.17M	-1,476.46M	-1,562.23M	-1,627.23M	-1,693.60M	-1,759.90M	-1,819.82M	-1,879.60M	-1,930.50M	-1,971.90M	-2,010.71M	-2,053.32M	-2,096.00M	-2,146.40M

Allogene Therapeutics Balance Sheet API

Pull Allogene Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ALLO&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/statements"
params = {"ticker": "ALLO", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/statements?ticker=ALLO&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();

API documentation

Allogene Therapeutics ALLO Balance Sheet (2017-2026)

Allogene Therapeutics Quarterly Balance Sheet

Allogene Therapeutics Balance Sheet API

Create an account

Sign In

Reset Password